Atypical Teratoid Rhabdoid Tumors (ATRT) Pipeline Insights

Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Atypical Teratoid Rhabdoid Tumors (ATRT) - Pipeline Insight, 2023" clinical trials has been added to ...

Related Keywords

Dublin ,Ireland ,Ipsen Pharma ,Pipeline Development Activities ,Novartis Pharmaceuticals ,Takeda Pharmaceuticals ,Teratoid Rhabdoid Tumors ,Atypical Teratoid Rhabdoid Tumors ,Emerging Drugs ,Atypical Teratoid Rhabdoid ,Pipeline Development ,Research And Markets ,Chemotherapy ,Immunotherapy ,Immunotherapy Drug ,Oncology Drugs ,Small Molecule ,Tumor Drug ,